| Names | |
|---|---|
| Preferred IUPAC name | 1,1,1,3,3,3-Hexafluoropropan-2-ol |
| Other names | 1,1,1,3,3,3-Hexafluoro-2-propanol HFIP Hexafluoro-2-propanol 1,1,1,3,3,3-Hexafluoroisopropanol Perfluoroisopropanol |
| Pronunciation | /ˌhɛksəˌflʊərəʊˌaɪsəˈprəʊpənɒl/ |
| Identifiers | |
| CAS Number | 920-66-1 |
| Beilstein Reference | 1721211 |
| ChEBI | CHEBI:47735 |
| ChEMBL | CHEMBL1230941 |
| ChemSpider | 11795 |
| DrugBank | DB14292 |
| ECHA InfoCard | 03a1d8f4-e7a7-4e43-ac3b-e4f4ef2fff1b |
| EC Number | 206-199-4 |
| Gmelin Reference | 11309 |
| KEGG | C01721 |
| MeSH | D006533 |
| PubChem CID | 72415 |
| RTECS number | MN1400000 |
| UNII | VUF0306K1M |
| UN number | UN1992 |
| Properties | |
| Chemical formula | C3H2F6O |
| Molar mass | 168.04 g/mol |
| Appearance | Colorless transparent liquid |
| Odor | sweet, musty |
| Density | 1.596 g/mL at 25 °C(lit.) |
| Solubility in water | miscible |
| log P | 0.2 |
| Vapor pressure | 11.4 hPa (20 °C) |
| Acidity (pKa) | 9.3 |
| Basicity (pKb) | pKb = 15.9 |
| Magnetic susceptibility (χ) | -35.5·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.277 |
| Viscosity | 1.62 mPa·s (20 °C) |
| Dipole moment | 1.86 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 212.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | –1146.9 kJ·mol⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -3535 kJ·mol⁻¹ |
| Hazards | |
| GHS labelling | GHS02, GHS05, GHS06 |
| Pictograms | GHS02,GHS05,GHS06 |
| Signal word | Danger |
| Hazard statements | H302, H314, H318, H335 |
| Precautionary statements | P210, P261, P264, P271, P280, P301+P310, P303+P361+P353, P304+P340, P305+P351+P338, P311, P312, P337+P313, P370+P378, P403+P233, P403+P235, P405, P501 |
| Flash point | +25 °C |
| Autoignition temperature | 415°C |
| Explosive limits | 4.9–16% |
| Lethal dose or concentration | LD50 (oral, rat): 1400 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Hexafluoroisopropanol (HFIP): "1,440 mg/kg (rat, oral) |
| NIOSH | MW3850000 |
| PEL (Permissible) | PEL: 1 ppm (8-hour TWA) |
| REL (Recommended) | 2.5 ppm |
| IDLH (Immediate danger) | 500 ppm |
| Related compounds | |
| Related compounds | Methanol Ethanol Isopropanol Trifluoroethanol Perfluoro-tert-butanol |
| Product Identification | |
|---|---|
| Product Name | Hexafluoroisopropanol |
| IUPAC Name | 1,1,1,3,3,3-Hexafluoro-2-propanol |
| Chemical Formula | C3H2F6O |
| Key Synonyms & Trade Names | HFIP, Hexafluoro-2-propanol, 1,1,1,3,3,3-Hexafluoroisopropanol |
| CAS Number | 920-66-1 |
| HS Code & Customs Classification | The most common customs classification for Hexafluoroisopropanol aligns with HS Code 290379, which covers fluorinated, brominated, or iodinated derivatives of acyclic alcohols. Classification adjusts based on product form, purity, and local regulatory requirements. Detailed grade and intended application sometimes influence specific national or regional sub-classification, especially if used in pharmaceutical, electronics, or specialty polymer sectors. |
Hexafluoroisopropanol is produced on industrial scale primarily for use as a specialty solvent and as an intermediate in the synthesis of fluorinated polymers, pharmaceuticals, and agrochemicals. Manufacturers must evaluate raw material sourcing for hydrofluorocarbons and control supplier variability, as trace precursors can impact final impurity profiles.
The process route selection—whether direct fluorination processes or indirect dehydrohalogenation—hinges on both cost efficiency and impurity management. In-house experience shows trace acid, water, and unreacted precursor residues have the highest likelihood to persist after crude distillation. Manufacturing imposes receiver monitoring, water separator protocols, and inert atmosphere handling to reduce risk of hydrolysis or peroxide formation.
Product grades are strictly defined against moisture, halide, and acid content, with specification sheets set per customer segment. High-purity electronics and pharmaceutical applications command tighter batch release criteria and expanded batch records, while commodity grades for polymerization may tolerate broader control limits, provided minimal impact on downstream polymer stability and color.
Various applications respond differently to grade-dependent properties: solvent power in peptide synthesis and spinning of specialty fibers depends on low trace water and acid; polymer intermediates demand stabilization additives and specific isotopic profiles, often monitored through GC, KF titration, and NMR. Supply chain clients often dictate the certification depth for each lot and may request on-site sampling before customs clearance—driven less by HS code than by downstream risk management.
Storage guidance, drum and bulk container selection, and transfer protocols are implemented based on volatility, hygroscopicity, and chemical aggressiveness observed during warehouse and tank farm operations. Exposure to atmospheric moisture or reactive metals alters both product grade and long-term handling requirements, leading to corrosion or off-spec formation.
Final product shipment adheres to both internal QA release criteria and client's analytical request, with documentation varying from COA/COC to full detail on trace residuals and batch genealogy. Border clearance and customs classification checks are built into batch management systems to ensure compliance with both domestic and international shipment protocols. Any batch traceability discrepancy results in enforced hold or reanalysis as standard manufacturer practice.
Production-scale HFIP presents as a clear, colorless liquid across most purity grades, but color can shift to pale yellow if contamination occurs or if material is exposed to air for prolonged periods. The characteristic odor is sharp and sometimes irritating at higher concentrations, which technicians notice quickly in confined areas. Melting and boiling points vary slightly based on residual impurities and moisture content, and exact data must be reviewed by batch, as even trace residuals can change observed values during incoming QC checks. Density shifts depending on grade, particularly between dry and aqueous variants, and is regularly validated by densitometry in process streams to catch deviations indicating off-specification production.
HFIP requires careful material compatibility assessment; the molecule aggressively seeks hydrogen bonding, showing strong affinity for moisture and hydrolysis-prone contaminants. In mixed or multiuse facility environments, operators must avoid contact with reactive metals and basic materials, and avoid combining with oxidizing agents, especially during process transfer or cleaning, as this may increase corrosion risk or byproduct formation. Minor exothermicity is noted during mixing with water or alcohols, which is controlled by routine dosing and temperature surveillance during solution preparations.
Technicians favor HFIP for high solubility in polar and certain non-polar solvents; this characteristic allows integration into varied downstream syntheses as solvent or reagent. Water pickup is rapid, and solution preparation must proceed in dry glassware and protected atmospheres to avoid grade drift from ambient humidity. Formulation specialists use Karl Fischer titration to ensure water content stays within specifications before analytical or synthetic deployment.
Grades range from technical to high-purity types, tailored to application and regulatory standards for the use environment. Customers in pharmaceutical and peptide synthesis demand near-anhydrous HFIP, with tight control on water, acid, and organic impurity limits, which require additional purification. Electron microscopy or semiconductor applications specify even lower ion and particle content. Commodity variants supply textile and polymer customers, where trace color and organics are less critical but overall purity and density remain important for reactor feed calibration.
Common monitored impurities include water, halogenated byproducts, low-molecular-weight acids, and residual solvents. Continuous process sampling supports early identification of impurity pick-up, and spectral (GC, NMR) fingerprints drive lot acceptance. The company maintains internal maximum level criteria based on each market’s end-use, and customers may define acceptance ranges tighter than baseline control in regulated applications. Process modifications can shift impurity profiles, so the QC team reviews each grade and batch traceability data before release.
Typical assessment methods in the QC lab include gas chromatography for organic impurities, Karl Fischer titration for moisture, NMR or FTIR for identity and major functional group verification, and optical measurement for color. Test standard and frequency adjust based on lot size, process route, intended market, and critical performance requirements from downstream operations. Any customer-supplied method or regulatory guidance is reviewed and, if validated, integrated into the routine batch release protocol.
Sourcing relies on consistent-grade hexafluoroacetone and isopropanol, with careful supply chain auditing to prevent contamination from incompatible packaging or degradation en-route. Stability and traceability of the feedstock directly impact downstream process reliability, so the procurement team works alongside quality to vet each new supplier. Shipping containers are inspected upon arrival for seal integrity and visible residue, followed by spot-checking contents against COA and in-house standards.
The most prevalent industrial synthesis route involves acid-catalyzed addition of hexafluoroacetone to isopropanol, generating HFIP through a well-documented mechanism with minimal side reactions under controlled conditions. Byproduct generation, such as HF or oligomeric fluorinated fragments, results from over-reaction or inexact temperature and pH control, so reaction monitoring and rapid quench protocols are embedded in the plant’s operational SOPs.
Operators rely heavily on automated dosing, in situ spectroscopic feedback, and thermal profiling at each reaction stage. After synthesis, fractional distillation under controlled pressure removes volatile contaminants. Ion exchange and fine filtration steps are applied in higher-purity requirements, and the plant maintains separate purification lines for grades susceptible to cross-contamination. Critical control points include reaction temperature, distillation fraction cut points, and atmospheric exposure times.
Batch progression is gated by in-process checkpoints: intermediate samples are reviewed for key impurity markers using rapid analytics, and only lots meeting all chromatographic, spectroscopic, and physical property targets proceed. Each release profile includes full documentation and comparison to both internal and customer specification records. Deviations trigger root-cause analysis and rework or disposal, never blending to reach spec.
HFIP's high polarity and unique hydrogen-bonding facilitate use as a versatile solvent and as a reagent for fluorinated intermediates. Nucleophilic substitution, esterification, and straightforward condensation reactions proceed with minimal catalyst under mild temperature, but stronger bases or nucleophiles introduce undesirable side-products. Reactions yielding specialty fluorinated ethers or protective groups in pharmaceutical syntheses illustrate its adaptability, but exact conditions depend on target reactivity and downstream product purity requirements.
Most modifications proceed without need for external catalysts; where used, acid or Lewis-acidic catalysts are favored. Temperature adjustments depend on sensitivity of co-reactants, and staff select inert atmospheres for water- or oxygen-sensitive transformations. Solvent selection often pairs HFIP with other fluorinated or aprotic media when higher selectivity is needed, balancing reactivity against contamination risks and ease of downstream isolation.
Key downstream chemicals include fluorinated ethers, specialty polymers, and peptide intermediates. End-use determines allowable impurity thresholds, and metabolic or industrial derivatives are increasingly explored in advanced materials and pharmaceutical pipelines. Scale-up of new derivatives requires collaboration across R&D, pilot, and quality teams to match process learnings and updated hazard assessments with evolving application requirements.
HFIP is stored in tightly sealed fluoropolymer or glass containers compatible with aggressive fluorinated solvents. Temperature control limits volatility losses and slows formation of acid breakdown products, so plant protocols specify cool, dry enclosure with minimal light penetration. Humidity exclusion matters most for higher-purity grades, and nitrogen blanketing is typical for long-term storage, with dew-point checks verifying atmospheric tightness. Product in-use cycles shorter than six months for high-precision fields; longer for general industrial grades where trace increases in water content or color are less critical to function.
Only high-grade PTFE, certain metals with protective coatings, or specialty glass avoid interaction with HFIP. Polyethylene, standard rubbers, and soft seals lead to leaching or degradation, and regular inspection and rotation eliminate ingress risk. Storage area setup includes dedicated bunding and leak detection as standard risk mitigation.
Shelf life correlates with storage integrity and initial water/activity content. Discoloration, odor shifts, or visible phase separation signal breakdown, at which point full requalification or batch rejection takes place. High-precision customers set tighter shelf-life windows, aligned with their regulatory and formulation stability needs.
HFIP falls under flammable liquid and acute toxicity categories. Standards and pictograms applied in the facility accord with regional chemical safety frameworks. Immediate labeling occurs after packaging, and inventory is segregated to avoid misidentification during transfer or decant.
Operator exposure risk rises during bulk transfer, blending, or maintenance. Inhalation at high vapor concentrations results in strong irritation and potential CNS effects. Liquid contact can damage skin and eyes rapidly. Technicians rely on full PPE—respiratory, chemical eye protection, gloves engineered for fluorinated solvent resistance—and local exhaust or fume hoods for bench-scale tasks. Rigorous training and signage reinforce procedural adherence in all handled zones.
Acute exposure studies indicate dose-dependent toxicity affecting respiratory, hepatic, and central nervous systems. Chronic exposure scenarios, particularly at sub-threshold chronic vapor levels, merit periodic medical monitoring for at-risk workers. Threshold limit values and exposure durations draw on regulatory data from government and trade bodies, with facility rules erring on the side of conservatism where uncertainty persists. Emergency spill response and waste handling must account for environmental persistence and bioaccumulation potential, with prompt neutralization, containment, and approved disposal methods enforced plant-wide.
Manufacturing HFIP hinges on access to high-purity starting fluorochemicals and effectively managed hydrogen fluoride processing. Most production lines operate continuously to guarantee material output aligns with planned order volumes. Actual capacity shifts with maintenance schedules, feedstock constraints, and downstream specialty application demand. Large-scale plants, especially those designed to cater to pharma and advanced polymer sectors, constantly monitor throughput and yield to prevent bottlenecks originating from upstream distillation or fluorination steps. Batch consistency remains a primary quality target—producers scrutinize chromatographic and spectroscopic profiles of every release lot to reduce risk of property drift between orders.
Lead times rely on a combination of in-process tank inventory and the stringency of customer purity requirements. For commodity-grade HFIP, standard lead times usually track with weekly or bi-weekly plant loading. Pharmaceutical-grade or R&D-focused batches may require additional production slotting for extra purification or documentation (such as validation of metal content, residual solvents, or class-specific impurities), which can extend total turnaround. Minimum order quantities usually reflect bulk tank handling efficiencies and packaging line setup costs. MOQs for packaged HFIP (e.g., 200L drums or 20L kegs) reflect shelf-life constraints and handling risk rather than just unit economics. Negotiated MOQs tend to flex for strategic customers or project-based supply agreements.
Standard packaging of HFIP includes fluorinated HDPE drums and stainless steel containers tailored to the product’s aggressive chemical properties. Logistic safety considers the risk of hydrogen fluoride liberation under storage mishap or excessive heat, so packaging specifications mirror both the physical hazard and downstream requirements (for example, regulatory transport certifications and traceable batch markings). Packaging size selection is tightly coupled to handling protocol at customer sites—research institutes tend to request small-volume certified bottles, whereas industrial polymer producers demand bulk packaging for seamless loading to reactors.
As a regulated fluorinated solvent, HFIP falls under strict shipping controls, requiring full declaration under IMDG/IATA/DOT rules for corrosive and toxic substances. Only authorized bulk carriers with HFIP-handling experience can typically be contracted. Payment terms reflect corporate risk management policy; first-time buyers may be required to pre-pay, while repeat customers typically work on net 30 or 60 days with volume-linked rebates or fixed price agreements. Currency volatility, especially for dollar-denominated raw materials, may prompt forward contracts at agreed foreign exchange rates.
HFIP pricing builds primarily from the cost of fluorinated base chemicals, most critically hexafluoropropylene (HFP) and hydrogen fluoride. Both are subject to tight supply-demand cycles and are sensitive to disruptions in the global fluorochemical value chain. Direct energy inputs, catalyst regeneration, and purification (notably multi-stage distillation and polishing) impact marginal production cost. Plant location proximity to reliable fluorine sources and anti-corrosion plant construction costs shape fixed cost load. Fluctuations in the price of energy (especially electricity and specialty refrigerants) create short-term shifts in operating costs, most persistent in regions with volatile power markets.
Raw material price swings link to several causes. Regulatory shutdowns or safety-driven slowdowns at Asia-based fluoro-chemical parks can cascade rapidly to global shortages. Unplanned downtime at major hydrogen fluoride or HFP plants reverberates through the specialty chemical supply chain. Trade actions, such as new import/export controls on fluorinated intermediates or tariffs, drive abrupt regional supply imbalances. Feedstock price instability transmits quickly to final HFIP pricing, especially for short-term spot orders.
Pricing for HFIP diverges sharply by grade and end-use certification. Pharma- or reagent-grade batches demand tighter impurity and water content control, requiring higher-cost purification and more frequent analytical validation. Industrial-grade material, meant for routine polymer synthesis, accepts higher background impurities and comes with a corresponding price discount. Grades intended for special coatings or lithium battery electrolytes may fall between these extremes, based on contamination risk and critical application parameters.
Packaging certification also drives cost: material packed for regulated transport (air, ocean, road) with full chain-of-custody labeling fetches higher premiums. Buyers seeking multiple certifications within a single order (for example, GHS, ADR, and REACH compliance) take on that extra cost in overall unit pricing.
HFIP market size directly mirrors the demand for downstream specialty polymers, pharmaceutical intermediates, and electronics applications. East Asia, North America, and Western Europe anchor both supply and demand due to high concentration of high-tech and pharmaceutical manufacturing sites. Plant expansions rarely keep pace with surges in demand, so short-term shortages remain a persistent risk.
| Region | Observations (2024-2026) |
|---|---|
| United States | Localized production capacity supports advanced materials and pharma demand; subject to raw material import squeeze if Asian supply tightens. |
| European Union | Tough REACH regulatory climate; regular audits of fluorochemical imports; high specialty application value chain. |
| Japan | Stable demand from fluoropolymer and precision electronics markets; premium placed on ultra-high purity batches. |
| India | Growing interest from pharmaceutical sector; dependent on imported fluorinated precursors; sporadic supply disruptions affect pricing stability. |
| China | Largest single block of global capacity; periodic local regulatory crackdowns on fluorochemical plants cause global ripples. Strategic stockpiling impacts world trade flows. |
Market modeling, based on three-year running averages and demand-side expansion in pharmaceutical and electronics manufacturing, suggests continuing upward pressure on HFIP prices through 2025 and into 2026. Regulatory tightening on hydrogen fluoride emissions and more frequent environmental safety audits in Asia are projected to sustain elevated cost levels. The absence of major new global production capacity points toward structural tightness, which favors contract-based, volume-linked pricing over spot deals for most buyers. Region-specific pricing gaps may widen, driven by local compliance costs and logistical hurdles.
Analysis utilizes internal order book data, regional customs and tariff statistics, fluorochemical feedstock price indices, and published regulatory bulletins. Direct customer inquiry and competitive intelligence from industry consortia inform short- and medium-term demand forecasting.
Producers across East Asia and Europe have announced new R&D trials for lower-residue HFIP formulations, focusing on lowering environmental exposure and improving analytical batch traceability. Market interest in battery and high-purity API applications is driving new certification projects for trace metal and organic contamination levels.
Regulatory agencies in China, EU, and the US are tightening disclosures for fluorinated intermediates, mandating more transparent reporting on plant emissions and waste byproducts. Several jurisdictions now require demonstration of impurity tracking and in-process cleaning validation for supply into pharmaceutical production.
Major HFIP producers have broadened in-house testing programs and invested in remote monitoring technology for hard-to-access process lines. Raw material approval protocols have become more rigid, especially for lots destined for pharma or electronics markets. Risk management teams are extending forward contract coverage for critical feedstock to smooth out volatility and reduce risk of unplanned plant outages cascading into customer delivery delays.
Hexafluoroisopropanol serves as a specialty solvent and intermediate in advanced chemical manufacturing. Major sectors rely on it for distinct roles:
| Application Sector | Typical HFIP Grade | Key Properties Controlled |
|---|---|---|
| Polymer Synthesis/R&D | Standard or Technical Grade | Moisture, Non-volatile Residue, Acid Number |
| Peptide/Pharma Synthesis | Analytical / Biograde | Trace Metals, UV Absorbance, Endotoxin, Peroxide Level |
| Medical Devices | Low Endotoxin Biograde | Bioburden, Endotoxin, Organic Impurities |
| Microelectronics/Coatings | High-Purity Industrial | Ionic Content, Acidity, Residuals |
Quality assurance and grade breakdown follow the end-use specification. For technical and standard material, in-process controls emphasize water content, color, and acidity—parameters that influence storage, handling, and compatibility with metering and mixing systems. Analytical and biograde material passes additional controls for metals, UV-active impurities, and biological contamination; factory release depends on upstream process stability as much as downstream purification and packaging.
Production teams coordinate with customer process engineers and formulators to clarify whether the intended use is technical (polymer process aid, industrial solvent) or regulated (biomedical, pharmaceutical). Defining application directs the rest of the assessment.
Compliance standards impose specific test and validation steps. Medical or pharma grade projects often trigger expanded trace impurity, bioburden, and migration assessments. Documentation, audit, and change notification requests flow from these standards and shape raw material sourcing and batch release.
Purity and impurity targets rest on both published process requirements and customer feedback. Moisture, acidity, and residue drive technical and R&D projects, while trace metals, peroxides, and bioburden weigh heavily in regulated markets. Both the type and level of impurity control are grade dependent and require tailored batch segregation and in-process control.
Commercial teams gather monthly or annual volume estimates and process constraints. For high-volume technical operations, standard grades are manufactured with cost and operational efficiency in mind. Low-volume, high-specification projects often receive more frequent analytical verification and customized packaging, affecting lead time and cost. Batch slotting and campaign planning start from confirmed forecasts.
Technical service and QC join together for application testing support. Representative samples from proposed grades undergo customer process trials and analytical review. Adjustments in purification, packaging, or batch labeling can follow customer validation outcomes. Batch-to-batch consistency, especially for regulated sectors, is routinely documented according to customer testing feedback.
Hexafluoroisopropanol (HFIP) production advances under routine oversight from our quality management team, implementing process controls in line with globally recognized management systems. Our production sites operate with documented procedures covering feedstock evaluation, batch tracking, and final product verification. Auditors regularly review calibration, traceability, and corrective action approaches. Certification to ISO 9001 frameworks allows external parties to verify that not just batch records, but also method qualifications and deviation controls, are maintained from raw material reception to packed product dispatch. These systems exist for accountability, not box-ticking, so that claims in supplier declarations match what is reality on the factory floor.
Due diligence for HFIP centers on both process and application requirements. Our teams evaluate grade requirements with each customer, from standard industrial use to specialized pharmaceutical or analytical applications. Certificates of Analysis (CoA) reflect batch-unique laboratory data: water content, acid/base titers, trace organofluorine residues, and other parameters as specified by downstream regulations or end-use industry protocols. Depending on region and sector, additional provisions for REACH registration, TSCA inventory status, or other regulatory tracking may apply. Product certification scope varies—analytical, semi-bulk, or high-purity syntheses impose different reference standards and impurity profiles.
Every delivered lot includes a CoA aligned to current analytical method validation. Where requested, supporting documentation may cover impurity maps, residual solvent analyses, or detailed chromatographic profiles based on customer specification or compliance requirement. Inspection reports, method descriptions, and change control histories originate from the primary production site; they reference batch-specific details for full traceability. On-site document retention supports audit and recall capabilities for all supplied HFIP lots.
Our HFIP line operates on a campaign basis, with raw material qualification prioritized according to seasonal supply variability and strategic inventory levels. Plant scheduling prioritizes continuity, leveraging established supplier agreements for critical fluorinated feedstocks so that customers can plan procurement without last-minute uncertainty. Business models accommodate frame contracts for predictable volumes as well as flexible purchase commitments, depending on market volatility and end user demand. We work directly with key partners to develop supply plans that align minimum order volumes, lead times, and logistical windows, ensuring that production capacity matches actual demand rather than theoretical nameplate numbers.
Core capacity allocation is determined by historical offtake, market demand projections, and contingency planning for key accounts. For HFIP, the main bottlenecks at the manufacturing level relate to precursor sourcing, purification bottlenecks, and waste management systems. Investments focus on debottlenecking purification and expanding safe handling infrastructure for hazardous intermediates, as these define real-world throughput rather than theoretical installed capacity. Orders are fulfilled from both campaign output and buffer stock, with priority for repeat partners and critical applications. Batch scheduling takes into account both domestic and export logistical constraints.
Sample applications follow a controlled procedure: prospective partners submit a detailed end-use and test protocol form. Samples are prepared from main production runs, not pilot lots or off-grade trial runs, so results are representative of industrial supply quality. Documentation supplied with samples matches commercial batch standards, including traceability, CoA, and relevant technical or regulatory data where available. Feedback from sample validation informs both technical support and adjustment to commercial supply parameters if needed.
Flexible supply arrangements can incorporate multiple elements: buffer stock management for critical usage, rolling forecast-based allocation, consignment options, or customized packaging and delivery sequencing. These modes are negotiated based on the customer’s operational realities—volume, safety requirements, traceability expectations, and regulatory landscape. Joint review meetings with partner companies address risk mitigation for both sides, helping anticipate raw material or supply chain disruptions and coordinate timely product release within mutually agreed specifications.
Research teams remain focused on optimizing synthetic routes for Hexafluoroisopropanol across multiple scales, especially for high-purity grades required in API and advanced materials sectors. Reactor packing, heat integration, and trace moisture removal are recurring topics in technical forums. Downstream users in polymer, pharmaceutical, and electronics sectors increasingly request process-tailored impurity profiles. Handling of process chlorides, non-volatile silica, and organofluorine trace contaminants determines suitability for each customer's process window.
Growing interest in high-performance resins, semiconductor etchants, and fluorinated intermediates fuels demand for refined grades. In particular, LC-MS sample prep and OLED display manufacturing require HFIP batches with batch-to-batch color and halide consistency. The market also sees trial orders for HFIP in environmental analysis, peptide synthesis, and microfluidic reagent systems. A designer grade for lithium-ion battery binder chemistry stands out as an emerging channel, especially in pilot lines where solvent recyclability and residue control are critical.
Managing hydrolytic stability and minimizing metallic/ionic impurities remain operational concerns. Plant engineers target low-ppm thresholds for iron, potassium, and chlorides, as even marginal deviations can cause downstream process fouling or catalyst poisoning. New cold-trap techniques and closed-system transfer reduce operator exposure and cross-contamination risk. Breakthroughs in azeotropic purification and rapid phase-separation methods have shortened production cycles without compromising batch quality, subject to customer acceptance protocols. Process analytics now verify product release at each critical control point, capturing possible off-spec incidents before final packing.
Order volumes for ultra-high-purity HFIP continue to rise from contract manufacturing partners and electronic materials supply chains, especially across East Asia and Northern Europe. Price movements remain closely tied to fluoro-carbon feedstock costs and byproduct management expenses. End-users in medical device coatings and peptide labs signal a shift toward smaller, high-value lots with rapid turnaround specifications.
Future HFIP manufacturing will likely increase modularity at the process level, with skid-mounted micro-plants tailored for export or satellite operations. Onsite recycling and closed-loop solvent recovery for large industrial HFIP users show proven cost and safety benefits. Integration with digital batch tracking and in-line FTIR adds transparency for both regulatory and supply chain audit requirements. Manufacturers focus on mono-contaminant removal rather than generic distillation, employing targeted scavengers and proprietary resin systems as the target application calls for.
Raw material selection now prioritizes fluorinated alcohol feed from suppliers with established environmental disclosures. Manufacturers comply with local and international restrictions on emissions of volatile organofluorines, using solvent recycling wherever physically and economically justified. Certain plant upgrades include energy recovery on overheads and condensates, and process changeovers favor reagents with lower greenhouse impact. R&D groups screen new purification aids and solvents for downstream biodegradability, making final product stewardship part of both production and technical support portfolios.
Technical teams provide direct consultation for every supply agreement, including confidential reviews of customer application requirements. Recommendations cover product grade selection, storage compatibility, and materials of construction for vessels and pipelines based on concentration, temperature, and process environment. Guidance extends to extractables, leachables, and possible batch contamination mechanisms based on real-world incidents and corrective case studies within the plant.
Process engineers offer optimization reviews for end-user batch and continuous systems, including solvent compatibility checks for polymer, pharma, peptide, and analytical uses. Analytical chemists conduct test runs to validate starting point conditions, process sampling frequency, and off-gassing behavior. Support includes on-site troubleshooting, technical bulletins on solvent handling, and assistance with regulatory disclosures for new application submissions.
After shipment, warranty and support include product return management in case of non-conformance, technical review of any batch-related customer claim, and periodic customer audits of plant quality control records. Repeat customers access batch data and impurity profiles directly through secure digital channels. Ongoing support covers regulatory updates affecting HFIP transport or application and plant-wide inventory management suggestions for reducing downtime and changeover losses.
In our production line, every stage from fluorination to purification takes place on site. Handling Hexafluoroisopropanol demands strict process control and real-time analytics. Our chemists manage batch consistency through in-line monitoring and instrument-driven feedback. Downtime between runs stays low due to routine equipment maintenance and process standardization.
HFIP draws attention from pharmaceutical, agrochemical, and specialty polymer manufacturers. It functions not just as a solvent but as a reaction medium that enables challenging transformations. In peptide synthesis, research groups rely on our material to cleave protecting groups and solubilize difficult substrates. For select fluoropolymer modification, production-grade HFIP acts as a unique monomer precursor.
End-users in medical device materials, organic electronics, and crop protection seek HFIP for high-performance product development. Consistent solvent properties support reproducibility in scale-up and quality outcomes in downstream processing.
Manufacturing Hexafluoroisopropanol at scale means tracking purity specification throughout each stage of production. Our QA team uses gas chromatography, NMR, and titration at multiple steps—contamination gets flagged before the bulk stage. Each lot is analyzed against baseline reference samples, with records held for full traceability. No batch advances without documented verification meeting end-use standards.
Our operation uses dedicated filling lines and fluoropolymer-compatible containers to mitigate the risk of product interaction or off-gassing. We supply HFIP in volumes suited for pilot plants and continuous production lines. High-volume drums and intermediate bulk containers, pressure-rated and sealed, maintain product stability throughout storage and transit.
Global supply chains benefit from our shipment scheduling and logistics oversight. We keep safety documentation up-to-date and partner with specialized carriers for regulated freight, covering routine deliveries and urgent replenishments.
Our technical team supports chemical engineers and formulators on process integration, material compatibility, and scale-up methodology. We field questions on HFIP handling, waste stream management, and container selection for corrosive or sensitive media. Experience with in-plant troubleshooting and regulatory documentation gives buyers a resource from first trial through to ongoing commercial use.
Controlling HFIP production in-house brings lower risk to the supply chain. Procurement teams count on us for direct feedback, up-to-date lead time information, and firm commitments on order quantities. Distributors build long-term programs on reliable delivery, detailed COA documentation, and forward planning around maintenance shutdowns or market swings.
Through process transparency, technical engagement, and logistics discipline, we focus on delivering a dependable sourcing experience to both manufacturers and procurement professionals that depend on Hexafluoroisopropanol for advanced applications.
Our production line for Hexafluoroisopropanol runs on strict quality management. Consistent performance across applications hinges on purity, and our HFIP typically delivers a minimum purity of 99.9%. Each batch goes through rigorous analysis using gas chromatography and titration methods, targeting organic and inorganic impurities well below recognized industry thresholds. These controls mean less trouble with unexpected side reactions or interference in downstream processing. It makes scale-up predictable whether it's used as a specialty solvent or intermediate.
Every drum of our HFIP comes with a documented boiling point averaging 58°C under atmospheric pressure. This is not just a figure in a book; our operational batches undergo distillation profile checks for phase cut precision. Our process engineers track this to ensure the material evaporates as expected in customers’ pilot runs and production lines. There’s no room for guesswork in solvent recovery or materials synthesis, so tight control on this property matters to operators and technicians alike. Fluctuations in the boiling point often signal off-target composition, and we catch any drift at source.
Low water content plays a critical role in the reliability of HFIP. Trace moisture introduces side reactions in polymer, pharmaceutical, and specialty chemical applications. We use Karl Fischer titration as a standard routine, and specs for our HFIP set water content below 0.02%. Drying columns and sealed transfer systems keep ambient humidity at bay. By investing in moisture-proof packaging and closed system filling, we prevent water pickup during storage and shipment, so finished product doesn’t carry any surprises to customer tanks.
HFIP should pour clear and colorless, but trace discoloration indicates possible metal or organic contamination from handling and storage. We keep close tabs on color standards through both visual inspection and UV-VIS spectrophotometry checks on every batch. This avoids the risk of introducing unknowns into sensitive chemistry, and customers see a consistently transparent material, right out of the container.
Because certain synthetic routes amplify reactivity if even minimal acid is present, we target acid numbers in finished HFIP below 0.0005 meq/g. Monitoring residual acids in our production cycle is a non-negotiable step. The aim: minimize risk for those handling polymerizations or advanced organic synthesis. Our technical team maintains these checks to ensure this often-overlooked spec does not become a source of downstream process failure or unwanted by-products.
Every property mentioned ties back to process and equipment choices at our facility. Precision rectification columns, frequent calibration of testing devices, and batch-to-batch traceability all feed into our output quality. We see firsthand how variability can disrupt production schedules for advanced materials or pharmaceuticals, which is why consistency in these key physicochemical markers supports our customers’ business outcomes.
Our technical service team engages with R&D, QA, and process engineers using our HFIP. We’ve supported root-cause analysis on polymer batch consistency and solvent recovery troubleshooting. The deep understanding of these core properties means our advice draws on real operational outcomes. Production reliability extends beyond the data sheet – it includes packaging, handling instructions, and evidence-backed recommendations for specific industrial needs.
From our position as direct producers of hexafluoroisopropanol (HFIP), straightforward answers about logistics and order policies matter. Anyone regularly involved with high-value, specialty fluorochemicals quickly learns that clarity up front keeps downstream projects on schedule and budgets legitimate. To that end, we set our minimum order quantity for HFIP bulk at 200 kilograms. This ensures efficient batch scheduling and transport, keeping overall costs competitive while protecting the integrity of the product through fewer breaks in the handling process. In smaller volumes, the risks of exposure and evaporation add up, so larger lots support quality standards as much as practicality in shipping and storage.
Our process for planning HFIP production starts with firm commitments. Once a customer confirms a bulk order, raw material assessments and capacity allocation kick off. Given that HFIP is produced through multi-step fluorination and purification stages, run sizes correlate tightly to final order size and required purity levels. For standard grades within the 200 kg minimum and common purity specifications, production and QA typically span three to four weeks from confirmation. Nesting one customer’s production with compatible orders runs more efficiently, so lead times can often be shortened for recurring buyers or those who coordinate blanket purchase agreements.
We emphasize traceability and documentation at each point in production. HFIP presents unique handling and containment challenges—strict system isolation and dedicated equipment prevent cross-contamination. This means every scheduled batch draws from fresh upstream precursors. For large projects or new markets where monthly or quarterly scheduling matters, it helps to share forecasts in advance. With this kind of transparency, our production planners can secure the appropriate feedstock and lock down factory slots, which means better assurance of on-time delivery. Last-minute, ad-hoc increases in order size naturally lengthen lead times, as our line capacity shifts dependably only by prioritizing confirmed bulk orders.
Shipping arrangements for HFIP always factor in legal requirements, packaging compatibility, and customer unloading infrastructure. We use lined drums or ISO-tanks engineered for highly corrosive, volatile solvents. All export shipments pass international transport checks and incorporate custom documentation. In bulk, HFIP’s shelf stability stays intact so long as temperature and sealing are maintained—hence our investment in climate-controlled storage for outbound shipments awaiting pickup or inspection. Customers who have specific receiving protocols or require specialized delivery windows benefit from coordinating in advance; this protects both parties from demurrage or unsuitable transfer conditions.
We have refined these logistics and policies over years of working with pharmaceutical, specialty polymer, and advanced materials partners worldwide. High consistency in lead time and minimum lot policy isn't just about simplifying our workflow—it’s how we maintain product quality batch to batch and deliver industrial value that research-driven sectors demand. Our approach keeps both our laboratory and industrial clients confident not just in the chemistry, but in the reliability of every transaction. For detailed grade information, shipment options, or integrated supply planning, our technical team is in direct contact for solution-oriented support.
Manufacturing hexafluoroisopropanol (HFIP) goes well beyond synthesis and quality control. The true test arrives at the storage bunker, the loading dock, and the trade routes where local fire marshals and customs authorities actually study your paperwork. Strict observance of chemical safety law is only the start. We invest in understanding both the letter and the intent of local and international rules, because every shipment reflects our responsibility.
HFIP has a strong reputation for volatility and corrosiveness. We never store it beside oxidants or incompatible acids. We ensure positive pressure ventilation, spark-free lighting, and strict exclusion of open flames. Our standard drums use fluoropolymer linings and UN-approved closures. Warehouse staff track every movement in a digitized manifest. Facility chemists verify the integrity of retaining walls and spill containment daily.
Each container leaves our production floor with a GHS-compliant label, hazard pictograms, and correct UN numbers—typically UN1992 for HFIP solutions. We attach Safety Data Sheets (SDS) updated to reflect the latest regional and global guidelines. Regulatory teams monitor changes in REACH, TSCA, and GHS so that every document stays current. This isn’t just procedure; a missing label or an outdated SDS can delay a shipment for weeks and expose us to regulatory fines.
We select drum and IBC sizes based on transit mode and end-user handling capability, not just cost. Sea shipments face humidity and temperature changes; we reinforce containers for long journeys. Any consignment above threshold volumes is accompanied by the appropriate transport emergency cards. Air and ocean routes both require alignment with IATA and IMDG protocols. Truck drivers receive routing information and copies of transport emergency instructions from our dispatch office. Transport manifests and packing lists refer back to our internal batch records and barcode the units for traceability.
Customs offices in Europe, Asia, and North America expect to see our full paperwork suite: Certificate of Analysis, shipping declaration, package labels in local script, and—often—a permit number or registration certificate. Our compliance team works with regulatory agencies to ensure our credentials meet or exceed every local hurdle. Onsite compliance audits by regulators or customers are welcomed since our process records are transparent.
Warehouse and shipping teams run annual hazardous materials refreshers. Spill drills use our own HFIP, not water dummies. Forklift crews wear chemical-resistant gloves and eye shields approved for strong industrial solvents. We report any close call or near-incident and invest in corrective action before mistakes can repeat.
As a direct manufacturer, the job is never done when raw material leaves our gate. We monitor global logistics updates, regulatory trends, and technology upgrades to ensure HFIP moves safely and legally to every customer. Every delivery carries not just our chemical, but our reputation.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales9@bouling-chem.com, +8615651039172 or WhatsApp: +8615651039172
